+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population



Rad50 c.687delT does not contribute significantly to familial breast cancer in a French population



Cancer Epidemiology Biomarkers and Prevention 18(2): 684-685



Mutations in DNA repair genes are known for their association with hereditary breast cancer. BRCA1 and BRCA2 are the major genes for high-penetrance familial breast and ovarian cancer, whereas mutations in ATM or Chek2 confer more modest cancer risk. Additional genes involved in DNA double-strand break repair have more recently been associated with breast cancer risk: heterozygosity for deleterious mutations in components of the Rad50-Mre11-Nbs1 complex seems to predispose to breast cancer. In particular, the c.687delT mutation in Rad50 conferred an odds ratio of 4.3 for the risk of breast cancer in a study of Finnish breast cancer families. To explore the contribution of this mutation to breast cancer in French families for which no BRCA mutation could be found, we analyzed the relevant exon in 618 familial breast cancer cases and 513 controls with no personal or familial history of breast cancer. Rad50 was analyzed in its entirety for 231 familial cases, with no clearly deleterious mutations detected. These data together suggest that although founder mutations may make Rad50 a significant breast cancer risk factor in certain populations, it is not a factor in others.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055342223

Download citation: RISBibTeXText

PMID: 19190165

DOI: 10.1158/1055-9965.epi-08-0971


Related references

Some common mutations of RAD50 and NBS1 in western populations do not contribute significantly to Chinese non-BRCA1/2 hereditary breast cancer. Breast Cancer Research and Treatment 121(1): 247-249, 2010

Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study. Breast Cancer Research 16(3): R58, 2014

Evaluation of RAD50 in familial breast cancer predisposition. International Journal of Cancer 118(11): 2911-2916, 2006

DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Research and Treatment 103(2): 209-217, 2007

Founder mutations in the LDL receptor gene contribute significantly to the familial hypercholesterolemia phenotype in the indigenous South African population of mixed ancestry. Clinical Genetics 55(5): 340-345, 1999

Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene. Molecular Oncology 2(4): 296-316, 2008

Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. International Journal of Cancer 86(6): 883-887, 15 June, 2000

Breast cancer resistance protein (BCRP) and sulfotransferases contribute significantly to the disposition of genistein in mouse intestine. Aaps Journal 12(4): 525-536, 2010

Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland. International Journal of Cancer 119(2): 472-475, 2006

Immunohistochemical evaluation of hormone receptor for routine practice of breast cancer: highly sensitive procedures significantly contribute to the correlation with biochemical assays. Applied Immunohistochemistry & Molecular Morphology 11(1): 62-72, 2003

Multiple measures of genomic instability in a familial breast cancer patient versus a sporadic breast cancer population. American Journal of Human Genetics 67(4 Suppl. 2): 84, 2000

The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. International Journal of Cancer 108(1): 54-56, 2004

Breast cancer low-penetrance allele 1100delC in the CHEK2 gene: not present in the Chinese familial breast cancer population. Advances in Therapy 25(5): 496-501, 2008

Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population. Oncology Letters 9(6): 2787-2790, 2015